A recent study found that regular ibuprofen users were 40% less likely to develop Parkinson’s disease.

Supplier News

The Council for Responsible Nutrition last month announced the opening of an international headquarters in Manno, Switzerland, globally extending the supplement association’s reach.

The new headquarters will be home to the Council for Responsible Nutrition-International, which will operate as a wholly owned subsidiary of CRN.

“This was a natural progression for CRN to formalize the work it’s been doing for decades by standing up for science-based principles for dietary/food supplements worldwide,” Mark LeDoux, CRN chairman, stated. “CRN-I will provide a new forum by which we can strengthen our current efforts, with a particular emphasis on promoting sound nutrition and food safety policies, and encouraging government bodies, regulators and other decision makers to make policy recommendations that are well-grounded in science. In this global economy, having a European-based platform from which to disseminate science-based policy recommendations has been imperative to maximize our influence on behalf of our multinational members doing business around the world.”

According to new research released last month, supplementation with ibuprofen may reduce the risk of developing Parkinson’s disease.

The study found regular users of ibuprofen were 40% less likely to develop Parkinson’s disease than people who didn’t take ibuprofen. Also, people who took higher amounts of ibuprofen were less likely to develop Parkinson’s disease than people who took smaller amounts of the drug. The results were the same regardless of age, smoking and caffeine intake, researchers noted.

Login or Register to post a comment.